Avid Bioservices Inc (CDMO)

[pphmtoolong]

Geo, as a true long, I do know some of the truth about Peregrine. The sad part of the truth is that Bavi-chemo, bavi-imaging, bavi-antiviral have yet to show any commercial value.

I do not blame Peregrine management or any assortment of villains. These bavi efforts just have not performed in the clinics or in the greedy heads of any potential BP partners.

Peregrine has two things going for it, along with a host of things against it. First it has Avid. A division that is expanding and making a profit. Second, it has one last shot at Bavi-immunotherapy combos. They might work, they might not.

I'm not sure we need to go through the negatives. Too many past failures and a current cost structure are big ones. Can't do anything about the past. However, the cost structure presents an opportunity for management to manage. We'll see.

GLTA, Paul